1. Home
  2. CDIO vs LOBO Comparison

CDIO vs LOBO Comparison

Compare CDIO & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • LOBO
  • Stock Information
  • Founded
  • CDIO 2017
  • LOBO 2014
  • Country
  • CDIO United States
  • LOBO China
  • Employees
  • CDIO N/A
  • LOBO N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • LOBO
  • Sector
  • CDIO Health Care
  • LOBO
  • Exchange
  • CDIO Nasdaq
  • LOBO NYSE
  • Market Cap
  • CDIO 6.4M
  • LOBO 6.4M
  • IPO Year
  • CDIO N/A
  • LOBO 2024
  • Fundamental
  • Price
  • CDIO $4.39
  • LOBO $0.45
  • Analyst Decision
  • CDIO Buy
  • LOBO
  • Analyst Count
  • CDIO 1
  • LOBO 0
  • Target Price
  • CDIO $60.00
  • LOBO N/A
  • AVG Volume (30 Days)
  • CDIO 41.0K
  • LOBO 879.2K
  • Earning Date
  • CDIO 08-11-2025
  • LOBO 04-29-2025
  • Dividend Yield
  • CDIO N/A
  • LOBO N/A
  • EPS Growth
  • CDIO N/A
  • LOBO N/A
  • EPS
  • CDIO N/A
  • LOBO N/A
  • Revenue
  • CDIO $19,902.00
  • LOBO $21,188,606.00
  • Revenue This Year
  • CDIO $1,434.82
  • LOBO $77.34
  • Revenue Next Year
  • CDIO $4,661.91
  • LOBO N/A
  • P/E Ratio
  • CDIO N/A
  • LOBO N/A
  • Revenue Growth
  • CDIO N/A
  • LOBO 36.92
  • 52 Week Low
  • CDIO $3.22
  • LOBO $0.42
  • 52 Week High
  • CDIO $53.10
  • LOBO $3.52
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 50.34
  • LOBO N/A
  • Support Level
  • CDIO $4.11
  • LOBO N/A
  • Resistance Level
  • CDIO $4.73
  • LOBO N/A
  • Average True Range (ATR)
  • CDIO 0.33
  • LOBO 0.00
  • MACD
  • CDIO 0.10
  • LOBO 0.00
  • Stochastic Oscillator
  • CDIO 65.03
  • LOBO 0.00

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: the Electric vehicles and accessories sales segment, which generates key revenue, and the software royalties and development and design services segment. It generates all of its revenue within the People's Republic of China.

Share on Social Networks: